We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
IonQ Sets Bold Quantum Goal but High Valuation Makes Investors Wary
Read MoreHide Full Article
Key Takeaways
IonQ plans to reach 800 logical qubits by 2027 and 80,000 by 2030 with a modular design.
Partnerships with AstraZeneca, DOE and Oak Ridge highlight IonQ's real-world progress.
IONQ stock rose 7.9% in the past 30 days but faces pressure due to widened loss estimates and high valuation.
IonQ (IONQ - Free Report) has outlined an ambitious plan to make quantum computers more real-world focused over the next few years. At the core of this plan are two key technologies — Oxford Ionics’ ion trap on a chip, which makes quantum systems smaller and easier to scale, and Lightsynq’s photonic interconnects, which allow different quantum modules to communicate quickly.
With these tools, IonQ aims to reach 800 logical qubits by 2027 and expand to 80,000 logical qubits by 2030. Its long-term goal is even bigger, with a vision of 10 million ion traps on a single chip that can be linked together through modular systems. This design would allow quantum computers to scale far beyond today’s limits while maintaining cost efficiency.
These goals are supported by steady progress. IonQ is close to achieving the #AQ 64 benchmark, an important measure of quantum performance. At the same time, it is showing how quantum can solve real-world problems. In drug discovery, IonQ worked with AstraZeneca (AZN - Free Report) and demonstrated a 20-times faster process. In energy, it partnered with the U.S. Department of Energy and Oak Ridge National Laboratory to test ways to improve the power grid. In artificial intelligence, IonQ is exploring new ways to speed up machine learning by combining quantum and classical methods.
How Are IONQ's Competitors Doing?
Rigetti (RGTI - Free Report) : Technologically, Rigetti is advancing superconducting gate-based hardware via its chiplet architecture, with a 36-qubit system available and a 100+ qubit system at 99.5% two-qubit fidelity expected by year-end 2025. This makes Rigetti well-positioned to scale while retaining optionality for partnerships or acquisitions.
D-Wave Quantum (QBTS - Free Report) : It is pursuing a commercially anchored growth strategy with strong M&A ambitions, backed by solid liquidity. D-Wave management recently highlighted plans for strategic acquisitions to accelerate its push into gate-model quantum computing, expanding beyond its annealing roots. Technologically, D-Wave launched Advantage2, its sixth-generation annealer and is investing in advanced cryogenic packaging to scale both annealing and gate-model systems.
IONQ's Price Performance, Valuation and Estimates
IonQ shares have gained 7.9% in the past 30 days but underperformed the Zacks Computer - Integrated Systems industry.
Image Source: Zacks Investment Research
IonQ’s forward 12-month price/sales ratio of 89.26 is far above the industry average, as you can see below.
Image Source: Zacks Investment Research
For IONQ, the Zacks Consensus Estimate for 2025 loss per share has widened over the past 30 days from 47 cents to 97 cents, as you can see below. The estimated figure, however, indicates a narrower loss than the year-ago reported loss of $1.56 per share.
Image: Bigstock
IonQ Sets Bold Quantum Goal but High Valuation Makes Investors Wary
Key Takeaways
IonQ (IONQ - Free Report) has outlined an ambitious plan to make quantum computers more real-world focused over the next few years. At the core of this plan are two key technologies — Oxford Ionics’ ion trap on a chip, which makes quantum systems smaller and easier to scale, and Lightsynq’s photonic interconnects, which allow different quantum modules to communicate quickly.
With these tools, IonQ aims to reach 800 logical qubits by 2027 and expand to 80,000 logical qubits by 2030. Its long-term goal is even bigger, with a vision of 10 million ion traps on a single chip that can be linked together through modular systems. This design would allow quantum computers to scale far beyond today’s limits while maintaining cost efficiency.
These goals are supported by steady progress. IonQ is close to achieving the #AQ 64 benchmark, an important measure of quantum performance. At the same time, it is showing how quantum can solve real-world problems. In drug discovery, IonQ worked with AstraZeneca (AZN - Free Report) and demonstrated a 20-times faster process. In energy, it partnered with the U.S. Department of Energy and Oak Ridge National Laboratory to test ways to improve the power grid. In artificial intelligence, IonQ is exploring new ways to speed up machine learning by combining quantum and classical methods.
How Are IONQ's Competitors Doing?
Rigetti (RGTI - Free Report) : Technologically, Rigetti is advancing superconducting gate-based hardware via its chiplet architecture, with a 36-qubit system available and a 100+ qubit system at 99.5% two-qubit fidelity expected by year-end 2025. This makes Rigetti well-positioned to scale while retaining optionality for partnerships or acquisitions.
D-Wave Quantum (QBTS - Free Report) : It is pursuing a commercially anchored growth strategy with strong M&A ambitions, backed by solid liquidity. D-Wave management recently highlighted plans for strategic acquisitions to accelerate its push into gate-model quantum computing, expanding beyond its annealing roots. Technologically, D-Wave launched Advantage2, its sixth-generation annealer and is investing in advanced cryogenic packaging to scale both annealing and gate-model systems.
IONQ's Price Performance, Valuation and Estimates
IonQ shares have gained 7.9% in the past 30 days but underperformed the Zacks Computer - Integrated Systems industry.
Image Source: Zacks Investment Research
IonQ’s forward 12-month price/sales ratio of 89.26 is far above the industry average, as you can see below.
Image Source: Zacks Investment Research
For IONQ, the Zacks Consensus Estimate for 2025 loss per share has widened over the past 30 days from 47 cents to 97 cents, as you can see below. The estimated figure, however, indicates a narrower loss than the year-ago reported loss of $1.56 per share.
Image Source: Zacks Investment Research
IONQ stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.